COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. (2020)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(20)30442-3
PubMed Identifier: 32853557
Publication URI: http://europepmc.org/abstract/MED/32853557
Type: Journal Article/Review
Volume: 21
Parent Publication: The Lancet. Oncology
Issue: 10
ISSN: 1470-2045